THÔNG TIN TÀI LIỆU
Thông tin cơ bản
Định dạng | |
---|---|
Số trang | 411 |
Dung lượng | 40,79 MB |
Nội dung
Ngày đăng: 11/12/2021, 15:21
Nguồn tham khảo
Tài liệu tham khảo | Loại | Chi tiết |
---|---|---|
[1] M. Janbon., J. Chaptal., A. Vedel., J. Schaap., Accidents hypoglycémiques graves par un sulfamidothiodiazol (le VK 57 ou 2254 RP)., Montpellier Med., 1942., 441., 21–22 | Khác | |
[2] E. U. Guillermo., M. B. Murphy., A. E. Kitabchi., Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome., Diabetes Spect., 2002., 15., 28-36 | Khác | |
[3] H. Knauf., E. Mutschler., Clinical Pharmacokinetics and Pharmacodynamics of Torasemide., Clin Pharmacokinet., 1998., 34(1)., 1-24 | Khác | |
[4] J. Ceras., N. Cirauqui., S. Pérez-Silanes., et. al., Novel sulfonylurea derivatives as H3 receptor antagonists., Preliminary SAR studies., Eur J Med Chem., 2012., 52., 1-13 | Khác | |
[5] C. Michaux., J. M. Dogné., A pharmacophore model for sulphonyl-urea (- cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors., Eur J Med Chem., 2003., 38(7-8)., 703- 710 | Khác | |
[6] A. Ameya., Chavan and R. P. Nandini., Sulfonylureas as Dual Acting Agents - Synthesis and Biological Activity., Journal of the Chinese Chemical Society., 2007., 54., 771-777 | Khác | |
[7] C. León., J. Rodrigues., D. N. Gamboa de., Synthesis and evaluation of sulfonylurea derivatives as novel antimalarials., Eur J Med Chem., 2007., 42(6)., 735-742 | Khác | |
[8] L. Pan., Y. Jiang., Z. Liu., L. Xing-Hai., et. al., Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agents., Eur J Med Chem., 2012., 50., 18-26 | Khác | |
[9] S. R. Walker., Trends and Changes in Drug Research and Development., Springer Science & Business Media., 2012., 109 | Khác | |
[10] M. S. Alam., K. B. Chetna., Evolution of sulfunylureas in the treatment of dametic mellitus., Chemistry &Biology Interface., 2013., 3., 4., 230-252 | Khác | |
[11] H. Seltzer., Diabetes, A Summary of Criticisms of the Findings and Conclusions of the University Group Diabetes Program (UGDP) 21., 976–979 | Khác | |
[12] A. Ohneda., Y. Maruhama., H. Itabashi., Vascular Complications and Long-Term Administration of Oral Hypoglycemic Agents in Patients with Diabetes Mellitus., Tohoku J. Exp. Med., 1978., 124., 205–222 | Khác | |
[13] R. David., Williams and L. Thomas., W. Lippincott and Wilkins., Foye’s Principles of Medicinal Chemistry., 5th Ed., 2005., 629 | Khác | |
[15] M. Thomson., Drug Information for Health Care Professional., 24th Ed., Vol I., 2004., 296 | Khác | |
[16] M. S. Greenfield., L. Doberne and M. Rosenthal., Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus., Diabetes., 1982., 31., 307-312 | Khác | |
[17] T. Y. Nelson., K. L. Gaines and A. S. Rajah., Increased cytosolic calcium. A signal for sulfonylurea-stimulated insulin release from beta cells., J. Biol. Chem., 1987., 262., 2608-2612 | Khác | |
[18] O. G. Kolterman., R. S. Gray and G. Shapiro., The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects., Diabetes., 1984., 33., 346-354 | Khác | |
[19] M. A. Strausbauch., S. J. Xu., J. E. Ferguson., et. al., Concentration and separation of hypoglycemic drugs using solid-phase extraction-capillary electrophoresis., J.Chromatogr. A., 1995, 717, 279-291 | Khác | |
[20] Pfizer., Glucotrol XL® Glipizide Extended Release Tablets Prescribing Information., New York., 2007 | Khác | |
[21] P. O. Bitzen., A. Melander., et. al., Influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia., Eur J Clin Pharmacol., 1988., 35., 31-37 | Khác |
TÀI LIỆU CÙNG NGƯỜI DÙNG
TÀI LIỆU LIÊN QUAN